SCHEMBL21756925

SCHEMBL21756925

COCc1cc(I)cc(F)c1C(C)C

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PRKCE Q02156 2/20 0.33
MYLK Q15746 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PRKCG P05129 1/20 0.33
MAPT P10636 1/20 0.33
PRKCA P17252 1/20 0.33
APEX1 P27695 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21756927 0.79 GABRA1 (0.31)
SCHEMBL21756926 0.79 GABRA1 (0.35)
SCHEMBL21756924 0.77 GABRA1 (0.41)
SCHEMBL21756947 0.76 SLC6A4 (0.32)
SCHEMBL21756932 0.76 ALDH1A1 (0.38) MEN1ALDH1A1MAPTKMT2ATDP1
SCHEMBL29329045 0.71 ALDH1A1 (0.36) PRKCEMYLKMEN1ALDH1A1PRKCG
SCHEMBL24869116 0.70 ADRA1A (0.32) PRKCEMYLKMEN1ALDH1A1PRKCG
SCHEMBL21756930 0.70 GABRA1 (0.35)
SCHEMBL21765276 0.70 GABRA1 (0.35)
SCHEMBL16592917 0.70 PRKCE (0.35) PRKCEMYLKMEN1ALDH1A1PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020039088-A2 NOVEL COMPOUNDS Xeniopro GmbH (DE) 2020-02-27 WO disclosed
WO-2020039094-A1 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERATIVE ACTIVITY Xeniopro GmbH (DE) 2020-02-27 WO disclosed
WO-2020039092-A2 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2020-02-27 WO disclosed
US-9403829-B2 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use SIGNAL PHARMACEUTICALS, LLC (US) 2016-08-02 US disclosed